Alternative screening methods may reduce mortality in prostate cancer

April 2013
Hem/Onc Today;4/25/2013, Vol. 14 Issue 8, p11
The article discusses the results of a study which showed that mortality was reduced by prostate cancer screening methods that increase the threshold for biopsy referral for older men and lessen screening among those with low prostate-specific antigen (PSA).


Related Articles

  • Screening and Prostate-Cancer Mortality in a Randomized European Study. Schr�der, Fritz H.; Hugosson, Jonas; Roobol, Monique J.; Tammela, Teuvo L.J.; Ciatto, Stefano; Nelen, Vera; Kwiatkowski, Maciej; Lujan, Marcos; Lilja, Hans; Zappa, Marco; Denis, Louis J.; Recker, Franz; Berenguer, Antonio; M��tt�nen, Liisa; Bangma, Chris H.; Aus, Gunnar; Villers, Arnauld; Rebillard, Xavier; van der Kwast, Theodorus; Blijenberg, Bert G. // New England Journal of Medicine;3/26/2009, Vol. 360 Issue 13, p1320 

    Background: The European Randomized Study of Screening for Prostate Cancer was initiated in the early 1990s to evaluate the effect of screening with prostate-specific�antigen (PSA) testing on death rates from prostate cancer. Methods: We identified 182,000 men between the ages of 50 and 74...

  • What's New in ... Quigley, Timothy // JAAPA: Journal of the American Academy of Physician Assistants (;Oct2009, Vol. 22 Issue 10, p50 

    The article presents two studies on the benefits and harms of prostate-specific antigen (PSA) screening. One of the studies reveal that PSA screening did not reduce prostate cancer mortality while the other study showed a 20% reduction in mortality in the subjects who underwent screening....

  • To be screened or not to be screened? Modeling the consequences of PSA screening for the individual. Wever, E M; Hugosson, J; Heijnsdijk, E A M; Bangma, C H; Draisma, G; de Koning, H J // British Journal of Cancer;Aug2012, Vol. 107 Issue 5, p778 

    Background:Screening with prostate-specific antigen (PSA) can reduce prostate cancer mortality, but may advance diagnosis and treatment in time and lead to overdetection and overtreatment. We estimated benefits and adverse effects of PSA screening for individuals who are deciding whether or not...

  • Prostate cancer: to screen or not to screen? Schroder, Fritz H. // BMJ: British Medical Journal (International Edition);2/13/93, Vol. 306 Issue 6875, p407 

    Examines the diagnosis of prostate cancer. Percentage of mortality caused by the disease; Treatment of cancer; Identification of cancers discovered at necropsy.

  • 153-14. PSA VALUE.  // Cortlandt Forum;11/25/2000, Vol. 13 Issue 11, p88 

    Cites advantages of prostate-specific antigen (PSA) screening. Ability of the PSA screening to detect stage 1 cancer; Concerns over PSA screening.

  • Screening for Prostate Cancer. CROSWELL, JENNIFER; YOUNG-ROK SHIN // American Family Physician;2/15/2013, Vol. 87 Issue 4, p283 

    An American Academy of Family Physicians evidence-based continuing medical education quiz on prostate cancer screening is presented.

  • Screening for early prostate cancer: what is the problem? Moffat, L. // Journal of the Royal College of Surgeons of Edinburgh;Apr2000, Vol. 45 Issue 2, p127 

    Screening has been applied to normal populations to detect early cancers. Prostate cancer is very common and can he detected at an early stage. Screening has not been introduced in the UK for this disease and the possible reasons for this are discussed. There is a strong case for evaluation of...

  • Let patients decide whether to pursue PCa screening. Morain, Claudia // Urology Times;May2001, Vol. 29 Issue 5, p28 

    Focuses on the debate regarding the timing of prostate cancer screening. Importance of allowing patients themselves to decide whether to pursue screening in the absence of definitive information; Chief arguments against early detection efforts; Rebuttals to the common arguments against prostate...

  • Informed Decision Making About Prostate Cancer Screening. Vickers, Andrew J. // Annals of Internal Medicine;3/17/2015, Vol. 162 Issue 6, p457 

    The article discusses a study on the screening of prostate cancer and mentions the need to reorient patients from the perception that prostate cancer is fatal.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics